197 related articles for article (PubMed ID: 37967663)
1. Longitudinal study of traumatic-stress related cellular and cognitive aging.
Wolf EJ; Miller MW; Hawn SE; Zhao X; Wallander SE; McCormick B; Govan C; Rasmusson A; Stone A; Schichman SA; Logue MW
Brain Behav Immun; 2024 Jan; 115():494-504. PubMed ID: 37967663
[TBL] [Abstract][Full Text] [Related]
2. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
3. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
4. Combination of plasma amyloid beta
Verberk IMW; Thijssen E; Koelewijn J; Mauroo K; Vanbrabant J; de Wilde A; Zwan MD; Verfaillie SCJ; Ossenkoppele R; Barkhof F; van Berckel BNM; Scheltens P; van der Flier WM; Stoops E; Vanderstichele HM; Teunissen CE
Alzheimers Res Ther; 2020 Sep; 12(1):118. PubMed ID: 32988409
[TBL] [Abstract][Full Text] [Related]
5. Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers.
Duggan MR; Peng Z; An Y; Kitner Triolo MH; Shafer AT; Davatzikos C; Erus G; Karikkineth A; Lewis A; Moghekar A; Walker KA
Neurology; 2022 Oct; 99(18):e2014-e2024. PubMed ID: 35985823
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
7. Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
Ebenau JL; Pelkmans W; Verberk IMW; Verfaillie SCJ; van den Bosch KA; van Leeuwenstijn M; Collij LE; Scheltens P; Prins ND; Barkhof F; van Berckel BNM; Teunissen CE; van der Flier WM
Neurology; 2022 Mar; 98(13):e1315-e1326. PubMed ID: 35110378
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
De Meyer S; Blujdea ER; Schaeverbeke J; Reinartz M; Luckett ES; Adamczuk K; Van Laere K; Dupont P; Teunissen CE; Vandenberghe R; Poesen K
Brain; 2024 Mar; 147(3):936-948. PubMed ID: 37787146
[TBL] [Abstract][Full Text] [Related]
9. For whom the bell tolls: psychopathological and neurobiological correlates of a DNA methylation index of time-to-death.
Hawn SE; Zhao X; Sullivan DR; Logue M; Fein-Schaffer D; Milberg W; McGlinchey R; Miller MW; Wolf EJ
Transl Psychiatry; 2022 Sep; 12(1):406. PubMed ID: 36153327
[TBL] [Abstract][Full Text] [Related]
10. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
11. Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.
Asken BM; VandeVrede L; Rojas JC; Fonseca C; Staffaroni AM; Elahi FM; Lindbergh CA; Apple AC; You M; Weiner-Light S; Brathaban N; Fernandes N; Boxer AL; Miller BL; Rosen HJ; Kramer JH; Casaletto KB
J Int Neuropsychol Soc; 2022 Jul; 28(6):588-599. PubMed ID: 34158138
[TBL] [Abstract][Full Text] [Related]
12. Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women.
Roberts AL; Liu J; Lawn RB; Jha SC; Sumner JA; Kang JH; Rimm EB; Grodstein F; Kubzansky LD; Chibnik LB; Koenen KC
JAMA Netw Open; 2022 Jun; 5(6):e2217698. PubMed ID: 35771577
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
Mattsson-Carlgren N; Salvadó G; Ashton NJ; Tideman P; Stomrud E; Zetterberg H; Ossenkoppele R; Betthauser TJ; Cody KA; Jonaitis EM; Langhough R; Palmqvist S; Blennow K; Janelidze S; Johnson SC; Hansson O
JAMA Neurol; 2023 Apr; 80(4):360-369. PubMed ID: 36745413
[TBL] [Abstract][Full Text] [Related]
14. The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies.
Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Heslegrave A; Zetterberg H; Thomas AJ; O'Brien JT
Parkinsonism Relat Disord; 2022 Aug; 101():111-116. PubMed ID: 35872565
[TBL] [Abstract][Full Text] [Related]
15. Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults.
Lu WH; Giudici KV; Morley JE; Guyonnet S; Parini A; Aggarwal G; Nguyen AD; Li Y; Bateman RJ; Vellas B; de Souto Barreto P;
Geroscience; 2022 Jun; 44(3):1489-1503. PubMed ID: 35445358
[TBL] [Abstract][Full Text] [Related]
16. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
[TBL] [Abstract][Full Text] [Related]
17. Investigation of bidirectional longitudinal associations between advanced epigenetic age and peripheral biomarkers of inflammation and metabolic syndrome.
Morrison FG; Logue MW; Guetta R; Maniates H; Stone A; Schichman SA; McGlinchey RE; Milberg WP; Miller MW; Wolf EJ
Aging (Albany NY); 2019 Jun; 11(11):3487-3504. PubMed ID: 31173577
[TBL] [Abstract][Full Text] [Related]
18. Mid-life epigenetic age, neuroimaging brain age, and cognitive function: coronary artery risk development in young adults (CARDIA) study.
Zheng Y; Habes M; Gonzales M; Pomponio R; Nasrallah I; Khan S; Vaughan DE; Davatzikos C; Seshadri S; Launer L; Sorond F; Sedaghat S; Wainwright D; Baccarelli A; Sidney S; Bryan N; Greenland P; Lloyd-Jones D; Yaffe K; Hou L
Aging (Albany NY); 2022 Feb; 14(4):1691-1712. PubMed ID: 35220276
[TBL] [Abstract][Full Text] [Related]
19. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
